CD34 selections from myeloma peripheral blood cell autografts contain residual tumour cells due to impurity, not to CD34+ myeloma cells

British Journal of Haematology

Volumn 93, Issue 3, 1996, Pages 613-622

  Willems, P ^a   Croockewit, A ^a   Raymakers, R ^a   Holdrinet, R ^a   Van Der Bosch, G ^a   Huys, E ^a   Mensink, E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ASO PCR; CD34; Immunoglobulin; Myeloma; PBCA

Indexed keywords

CD34 ANTIGEN; OLIGONUCLEOTIDE;

ARTICLE; AUTOGRAFT; CASE REPORT; HUMAN; HUMAN CELL; MINIMAL RESIDUAL DISEASE; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

EID: 0029949994     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1677.x     Document Type: Article

References (28)

1. Areman, E.M., Culli, H., Aacher, R.A., Cottler-Fox, M. & Deeg, H.J. (1990) Automated isolation of mononuclear cells using the Fenwal CS3000 blood cell separator. Bone Marrow Purging and Processing (ed. by E. M. Aremad), p. 379. Alan R. Liss, Philadelphia.
2. Bakkus, M.H.C., Heirman, C., Van Riet, I., Van Camp, B. & Thielemans, K. (1992) Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood, 80, 2326-2335.
3. Barlogie, B., Alexanian, R., Dicke, K.A., Zagars, G., Spitzer, G., Jagannath, S. & Horowitz, L. (1987) High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma. Blood, 70, 869-872.
4. + B cells in the blood of patients with multiple myeloma express clonotypic 1gH sequences. Blood, 84, 385a.
5. Bersagel, P.L., Belch, A.R. & Pilarski, L.M. (1994) The blood B cells and bone marrow plasma cells in a patient with multiple myeloma include cells with the same N-Ras mutation. Blood, 84, 524a.
6. Billadeau, D., Blackstadt, M., Greipp, P., Kyle, R.A., Oken, M.M., Kay, N. & Van Ness, B. (1991) Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantitation of residual disease. Blood, 78, 3021-3029.
7. Billadeau, D., Quam, L., Thomas, W., Kay, N., Greipp, P., Kyle, R., Oken, M.M. & Van Ness, B. (1992) Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood, 80, 1818-1824.
8. Bird, J.M., Bloxham, D., Samson, D., Marcus, R.E., Russell, N.H., Kelsey, S.M., Newland, A.C. & Apperley, J.F. (1994) Molecular detection of clonally rearranged cells in peripheral blood progenitor cell harvests from multiple myeloma patients. British Journal of Haematology, 88, 110-116.
9. Brenner, M.K., Rill, D.R., Moen, R.C., Krance, R.A., Micro, J.J., Anderson, W.F. & Ihle, J.N. (1993) Gene marking to trace origin of relapse after autologous bone marrow transplantation. Lancet, 341, 85-86.
10. Buluwela, L., Albertson, D.G., Sherrington, P., Rabbitts, P.H., Spurr, N. & Rabitts, T.H. (1988) The use of chromosomal translocations to study human immunoglobulin gene organization: mapping Dh segments within 35 kb of the Cμ gene and identification of a new Dh locus. European Molecular Biology Organization Journal, 7, 2003-2010.
11. Deisseroth, A.B., Zu, Z., Claxton, D., Hanania, E.G., Fu, S., Ellerson, D., Goldberg, L., Thomas, M., Janicek, K., Anderson, W.F., Hester, J., Korbling, M., Durett, A., Moen, R., Berenson, R., Heimfeld, S., Hamer, J., Calvert, L., Tibbits, P., Talpaz, M., Kantarjian, H., Champlin, R. & Reading, C. (1994) Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood, 83, 3068-3076.
12. Durie, B.G.M. & Salmon, S.E. (1975) A clinical staging system for multiple myeloma. Cancer, 36, 842-854.
13. + stem cells do not contain clonal myeloma cells. Blood, 86, 381-389.
14. Gore, M.E., Selby, P.J., Viner, D., Clark, P.I., Meldrum, M., Millar, B., Bell, J., Maitland, J.A., Milan, S., Judson, I.R., Zuaible, A., Tillyer, C., Slevin, M., Malpas, J.S. & McElwain, T. (1989) Intensive treatment of multiple myeloma and criteria for complete remission. Lancet, ii, 879-882.
15. Gribben, J.G., Freedman, A.S., Neuberg, D., Roy, D.C., Blake, K.W., Woo, S.D., Grossbard, M.L., Rabinowe, S.N., Coral, F., Freeman, G.J., Ritz, J. & Nadler, L.M. (1991) Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B cell lymphoma. New England Journal of Medicine, 325, 1525-1533.
16. Ichihara, Y., Matsuoka, H. & Kurosawa, Y. (1988) Organization of human immunoglobulin heavy chain diversity gene loci. European Molecular Biology Organization Journal, 7, 4141-4150.
17. Innis, M.A., Myambo, K.B., Gelfand, D.H. & Brow, M.A. (1988) DNA sequencing with Thermophilus aquaticus DNA polymerase and direct sequencing of polymerase chain reaction amplified DNA. Proceedings of the National Academy of Sciences of the United States of America, 85, 9436-9440.
18. Jagannath, S., Barlogie, B., Dicke, K., Alexanian, R., Zagars, G., Cheson, B., Lemaistre, F.C., Smallwood, L., Pruitt, K. & Dixon, D.O. (1990) Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors. Blood, 76, 1860-1866.
19. Kabat, E.A., Wu, T.T., Perry, H.M., Gottesman, K.S. & Foeller, C. (1991) Sequence of Proteins of Immunological Interest, 5th edn. U.S. Department of Health and Human Sciences, NIH publication no. 91-5242, Washington, DC.
20. Mariette, X., Fermand, J.P. & Brouet, J.C. (1994) Myeloma cell contamination of peripheral blood stem cell grafts in patients with multiple myeloma treated by high-dose therapy. Bone Marrow Transplantation, 14, 47-50.
21. Matsuda, F., Shin, E.K., Hirabayashi, Y., Nagaoka, H., Yoshida, M., Zong, S.Q. & Honjo, T. (1990) Organization of variable region segments of the human immunoglobulin heavy chain: duplication of the D5 cluster within the locus and the interchromosomal translocation of variable region segments. European Molecular Biology Organization Journal, 9, 2501-2506.
22. Pellat-Deceunynck, C., Bataille, R., Robillard, N., Harousseau, J.L., Rapp, M.J., Juge-Morineau, N., Wijdenes, J. & Amiot, M. (1994) Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells. Blood, 84, 2597-2603.
23. Ravetch, J.V., Siebenlist, U., Korsmeyer, S., Waldmann, T. & Leder, P. (1981) Structure of the human immunoglobulin μ locus: characterization of embryonic and rearranged J and D genes. Cell, 27, 583-591.
24. + peripheral blood progenitor cells after high dose chemotherapy for patients with advanced multiple myeloma. Blood, 86, 390-397.
25. Takishita, M., Kosaka, M., Goto, T. & Saito, S. (1994) Cellular origin and extent of clonal involvement in multiple myeloma: genetic and phenolypic studies. British Journal of Haematology, 87, 735-742.
26. Vescio, R.A., Cao, J., Hong, C.H., Newman, R., Lichtenstein, A.K. & Berenson, J.R. (1993) Somatic hypermutation of Vh genes in multiple myeloma is unaccompanied by intraclonal diversity. Blood, 82, 259a.
27. Vescio, R.A., Hong, C.H., Cao, J., Kim, A., Schiller, G.J., Lichtenstein, A.K., Berenson, R.J. & Berenson, J.R. (1994) The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma. Blood, 84, 3283-3290.
28. Yamada, M., Wasserman, R., Reichard, B.A., Shane, S., Caton, A.J. & Rovera, G. (1991) Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes. Journal of Experimental Medicine, 173, 395-407.